Bioregenx (BRGX) Amortization of Deferred Charges (2024 - 2025)
Bioregenx (BRGX) posted quarterly Amortization of Deferred Charges of $1976.0 for Q3 2025, down 77.05% year-over-year from $8609.0 in Q3 2024, and up 265.22% quarter-over-quarter from -$1196.0 in Q2 2025.
Bioregenx (BRGX) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends
Bioregenx's Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at $1976.0 for Q3 2025.
- In Q3 2025, Amortization of Deferred Charges fell 77.05% year-over-year to $1976.0; the TTM figure through Mar 2026 stood at $780.0 (down 98.05% YoY), while the FY2025 annual figure was $2295.0, down 95.38% from the prior year.
- Amortization of Deferred Charges for Q3 2025 stood at $1976.0, up from -$1196.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $16213.0 in Q4 2024, with the low at -$1196.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn |
| 10 | Bioregenx | 9.72 Mn | 9.67 Mn | 348,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,976.00 |
| Sep 30, 2025 | 1,976.00 |
| Jun 30, 2025 | -1,196.00 |
| Jun 30, 2025 | -1,196.00 |
| Mar 31, 2025 | 1,515.00 |
| Mar 31, 2025 | 1,515.00 |
| Dec 31, 2024 | 16,213.00 |
| Dec 31, 2024 | 16,213.00 |
| Sep 30, 2024 | 8,609.00 |
| Sep 30, 2024 | 8,609.00 |
| Jun 30, 2024 | 13,573.00 |
| Jun 30, 2024 | 13,573.00 |
| Mar 31, 2024 | 11,228.00 |
| Mar 31, 2024 | 11,228.00 |